1. Home
  2. TSN vs MEDP Comparison

TSN vs MEDP Comparison

Compare TSN & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyson Foods Inc.

TSN

Tyson Foods Inc.

HOLD

Current Price

$52.19

Market Cap

18.2B

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$622.73

Market Cap

16.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSN
MEDP
Founded
1935
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Meat/Poultry/Fish
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.2B
16.6B
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
TSN
MEDP
Price
$52.19
$622.73
Analyst Decision
Buy
Hold
Analyst Count
10
12
Target Price
$66.90
$473.17
AVG Volume (30 Days)
3.0M
172.6K
Earning Date
05-04-2026
04-22-2026
Dividend Yield
3.21%
N/A
EPS Growth
N/A
20.98
EPS
1.49
8.53
Revenue
$54,441,000,000.00
N/A
Revenue This Year
$5.74
$13.19
Revenue Next Year
$1.14
$7.75
P/E Ratio
$35.53
$72.09
Revenue Growth
2.12
N/A
52 Week Low
$50.56
$373.00
52 Week High
$69.48
$677.90

Technical Indicators

Market Signals
Indicator
TSN
MEDP
Relative Strength Index (RSI) 37.99 63.83
Support Level $50.71 $575.89
Resistance Level $59.81 $629.30
Average True Range (ATR) 1.21 13.17
MACD 0.04 1.74
Stochastic Oscillator 27.02 94.08

Price Performance

Historical Comparison
TSN
MEDP

About TSN Tyson Foods Inc.

Tyson Foods is a protein-focused food producer, selling raw chicken, beef, pork, and prepared foods. Chicken and beef are its two largest segments, composing about 40% and 30% of sales, respectively. Prepared foods constituted 18% of fiscal 2025 sales and include brands like Tyson, Jimmy Dean, Hillshire Farm, Ball Park, and Sara Lee. However, most of these are in product categories rife with competition where Tyson does not have a massive market share lead. Tyson sells some products overseas, but the international segment accounts for just 4% of total revenue. The company is an active acquirer, with more recent years' purchases focused on international and food-service markets.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: